Skip to content

Advertisement

Cancer Nanotechnology

Basic,Translational and Clinical Research

Cancer Nanotechnology Cover Image
Open Access

The study of toxicity and pathogenicity risk of Potato Virus X/Herceptin nanoparticles as agents for cancer therapy

  • Neda Esfandiari1Email author,
  • Mohsen Karimi Arzanani2, 3 and
  • Mina Koohi-Habibi4
Cancer NanotechnologyBasic,Translational and Clinical Research20189:1

https://doi.org/10.1186/s12645-018-0036-6

Received: 15 June 2017

Accepted: 18 January 2018

Published: 29 January 2018

Abstract

Background

Nowadays, viral nanoparticles (VNPs) have attracted a lot of attention, although some are concerned that VNPs may reflect on viral entry of virus into animal or plant cells. In the present study, it aimed to investigate the pathogenesis of VNPs formed by Herceptin (Trastuzumab) and the viral nanoparticles derived from the filamentous plant virus Potato Virus X (PVX-HER) in host plant.

Methods

Flow cytometry was used to evaluate the toxicity of plant virus alone (free-PVX) in two HER2+ cancer cells and normal cells. Furthermore, the pathogenesis of PVX-HER was tested by ELISA, Western blot, and RT-PCR.

Results

The results indicated that PVX-HER failed to cause disease in the host plant. Furthermore, cancer and normal cell lines could evade the apoptosis and necrosis by the free viral nanoparticles (free-PVX). This study suggests that the problem of toxicity considered as a challenging factor in most nanoparticles was not observed in this plant virus nanoparticle.

Conclusions

Finally, the safety of the environment was confirmed. The present research is the first study which focused on VNPs based on safety perspective that can be used for drug delivery carriers.

Keywords

Potato Virus X HerceptinNanoparticlesToxicityMolecular biologyCancer cells

Background

Over the last few decades, the use of nanoparticles in drug delivery has been emphasized to optimize the effect of drugs, enable high-specificity targeted delivery, and reduce toxic side effect. Furthermore, the most current nanostructures including dendrimer, micelles, carbon nanotube, inorganic nanoparticles, polymerase, and viral nanoparticles (VNPs) are characterized as the targeted drug delivery (Mody et al. 2014).

Nowadays, large types of nanomaterials are being developed. VNPs, as one of the natural bionanomaterials, offer several advantages over the conventional synthetic particles due to self-assembly, biocompatibility, biodegradability, inexpensive, and large-scale production (Yoo et al. 2011). VNPs have been widely developed and used in medicine during the last few years (Aniagyei et al. 2008; Hefferon 2016; Van Kan-Davelaar et al. 2014; Young et al. 2008). VNPs have been genetically and chemically reprogrammed to be used in drug/gene delivery (Campos and Barry 2007; Manchester and Singh 2006; Steinmetz 2013), vaccines (Hefferon 2016; Lee et al. 2016; Peruzzi and Chiocca 2016), and nanomaterials (Lebel et al. 2016; Niu et al. 2007; Rong et al. 2008). VNPs based on plant viruses are extremely advantageous, because they are less likely to interact with mammalian cells and accordingly reduce the unpleasant side effects (Steinmetz 2010). Various types of plant viruses are extensively used for VNPs (Culver et al. 2015; Lico et al. 2015). Although filamentous and rod-shaped VNPs have increased tumor homing properties, most of the studies conducted in nanomedicine application have focused more on spherical plant virus (Biabanikhankahdani et al. 2016; Bruckman et al. 2014; Le et al. 2017; Shukla et al. 2013; Wen et al. 2012). Regarding targeted drug delivery, the use of VNPs in transferring therapeutic products to specific cells to treat cancer and infectious diseases is considered as one of the emerging fields. In addition, these VNPs can significantly contribute to the improvement of medical imaging and more efficiency of vaccination. Progress in this field needs a comprehensive understanding of viruses and loading the drugs. Nevertheless, it is very important to focus on the destructive effects, toxicity of nano-carriers to the body, and environment while emphasizing their use.

Potato Virus X (PVX) is more common in growing potatoes on the farms and infects a wide range of plant hosts, especially in Solanaceae family. (King et al. 2011) Some species of PVX cause devastating disease in the fields and it can induce a significant economic loss in synergistic co-infection with some viruses, especially Potyviruses (Bance 1991).

PVX is a type member of the plant virus Potexvirus genus and Alphaflexiviridae family. The virus is easily transmitted mechanically. The particles of flexible filamentous virus are about 500 nm long and 15 nm wide. PVX contains a single-stranded positive-sense RNA genome of about 6.4 Kb in length including five open reading frames (ORFs). ORF1 encodes the putative viral RNA-dependent RNA polymerase (RdRp), which is about 166 kDa and has three motifs of methyltransferase, helicase, and replicase (Mentaberry and Orman 1995). ORFs 2–4 are formed as triple gene block, which can encode TGBp1, TGBp2, and TGBp3 for about 25, 12, and 8 kDa, respectively, required for virus cell-to-cell movement (Bayne et al. 2005). The involvement of the CP protein was encoded by ORF5 in a systemic infection to replicate the genome and packaging of the RNA to form complete virus particles was suggested for PVX (Allan Granoff 1999).

Breast cancer was regarded as one of the most common types of cancer during 2012. Approximately, 20–30% of the patients with breast cancer are HER2-positive, which is more aggressive than other types of breast cancer (Armuss 2014). Herceptin (Trastuzumab) was approved as an antibody-targeted therapy for breast cancer by FDA. Herceptin is a humanized monoclonal antibody which can prevent from proliferating the cells and transducing the signals (Hudis 2007).

Esfandiari et al. reported new isolated of PVX, (Esfandiari et al. 2009) which was conjugated and characterized for the monoclonal antibody Herceptin (PVX-HER). In addition, PVX-HER increased the death of HER2+ breast cancer cells (SKBR3 and SKOV3) in comparison to the free Herceptin (free-HER) (Esfandiari et al. 2016).

In the present study, free-PVX (PVX that is not conjugated with Herceptin) was used to evaluate the toxicity of the plant virus alone as a VNP on two cancer cell lines and non-tumorigenic epithelial breast cell line (MCF-12A) as a normal cell. Accordingly, the cells were examined using flow cytometry after 24 h. Furthermore, all PVX-HER conjugation stages were conducted on the virus leading to the creation of PVX–PVX particles. In the next procedure, the produced particle was made to interact with SKBR3, SKOV3, and MCF-12A by flow cytometry. Finally, the pathogenicity of this PVX-HER nanoparticle was investigated in Nicotiana benthamiana as one of the indicator plants of PVX indicator plants of PVX. For this purpose, serological and molecular analyses were employed to detect PVX in inoculated N. benthamiana by ELISA, Western blot, and RT-PCR.

Methods

A large number of plant viruses can successfully infect N. benthamiana, as one of the most widely used experimental hosts in plant virology. In addition, N. benthamiana is gaining popularity in plant viral purification and large quantities of protein both rapidly and economically (Goodin et al. 2008). PVX is also able to establish infection in N. benthamiana (Aguilar et al. 2015). Thus, to investigate the large-scale purified virus, PVX used for inoculation of N. benthamiana in phosphate buffer (pH 7.2). Then, the leaves were harvested and purified within 2–3 weeks after inoculation of N. benthamiana (Senanayake and Mandal 2014). Accordingly, 100 g of the leaves were homogenized with 0.1-M phosphate buffer. Furthermore, the leaves were centrifuged at 7800g for 20 min after filtration with cheesecloth. 0.02-M NaCl and 4% PEG were added to the supernatant and centrifuged at 7800g for 30 min. The pellet was suspended in 1% Triton X-100 and 0.05-M phosphate buffer and centrifuged at 7800g for 10 min. In the next procedure, the supernatant was centrifuged in 30% sucrose gradient at 72,500g for 150 min using ultracentrifuged Backman Ti 70 rotor (Salazar 1993). Finally, the pellet was suspended in phosphate buffer (0.05 M, pH 7.2). Furthermore, the purity of virus was confirmed by SDS-PAGE and UV/Vis spectroscopy.

To obtain PVX-Herceptin nanoparticle (PVX-HER), EDC/sulfo-NHS (1:2.5) was used to conjugate Herceptin (IV infusion) to PVX (Esfandiari et al. 2016). In addition, EDC/sulfo-NHS cross linker was used to conjugate PVX–PVX during a two-step process. First, PVX (5 µg/µl) was incubated with EDC/sulfo-NHS (2 mM/10 mM) for 4 h, and accordingly, PVX-linker and another PVX particle (5 µg/µl) were conjugated for 2 h. Furthermore, free-PVX was purified virus without any conjugation.

Mechanical inoculation

To study the pathogenicity of PVX-HER on plants, N. benthamiana plants as a PVX indicator were set up in three rows and each row contained 12 plants. Next, plants inoculated with PVX-HER nanoparticle and PVX (as a positive control) in a buffered solution containing 0.05-M phosphate buffer pH 7.2, 2% PVP (Esfandiari et al. 2006). The development of symptoms on the plants was observed after 3 weeks (Senanayake and Mandal 2014; Zhao et al. 2001).

Elisa

The virus accumulation increased at 21-day post-inoculation with PVX (Senanayake and Mandal 2014). Accordingly, leaves of N. benthamiana 3 weeks after inoculation with PVX-HER, free-PVX, and healthy plant as a negative control were tested by sandwich ELISA assay in 96-well plates (Nunk Denmark). Each well was coated with PVX-specific antibodies (DSMZ, PV-0027) diluted in coating buffer. Then, the samples were prepared in PBST buffer, pH 7.4 (containing 2% PVP) added to the well and incubated at 37 °C overnight. In addition, the secondary antibody (Goat–anti-rabbit IgG-HRP, ab6721) was diluted and added to each well. After washing the plate three times with PBST buffer pH 7.4, 100 µl of TMB solution (3, 3′, 5, 5′-tetramethylbenzidine, T0565 Sigma) was added to each well and incubated for 15 min at the room temperature. The reaction was stopped by 100 µl/well of stopping solution. Then, the absorbance was read at 450 nm using ELISA reader (ELX 800, Biotek). PVX-HER, free-PVX, and negative control should be performed in triplicate.

SDS-PAGE and Western blot

The leaves of N. benthamiana were separately inoculated with PVX-HER and free-PVX. After 3 weeks, the leaves were extracted in 0.05-M phosphate buffer pH: 7.2 and boiled for 5 min. The boiled samples were loaded into 4–12% acrylamide gels electrophoresis.

PVX-HER, free-PVX, positive control (purified PVX), negative control (without inoculating healthy N. benthamiana leaves), and a protein marker (prestained protein ladder, Thermo; 2616) were run at 100 V for 45 min. Then, proteins were transferred into nitrocellulose membrane at 350 mA for 90 min. After blocking in 4% nonfat dry milk in 37 °C for 2 h, the PVDF membrane was blotted by PVX antibody (DSMZ, PV-0027) at 4 °C overnight. After washing the membrane with PBST buffer, it was incubated with goat polyclonal secondary antibody to rabbit IgG-HRP (Abcam ab6721) for 2 h. In the next procedure, ECL chemiluminescent substrate kit (GE Healthcare, Advance Western Blotting Detection Kit, RPN 2235) was used to detect the visualized protein bands. Finally, PVX-HER, free-PVX, positive control, and negative control were compared to each other.

Reverse transcription polymerase chain reaction (RT-PCR)

Total RNA was isolated from 100-mg infected leaves at N. benthamiana 14-day post-inoculation with PVX-HER, free-PVX, and healthy plant (non-inoculated as a negative control) by RNeasy plant mini kit (Qiagen RNeasy Plant Mini Kit (cat#74904)). The cDNA of RNA virus was synthesized using M-MuLV reverse transcriptase (200 U/µl), total RNAs, and the reverse specific primer. This reaction was incubated at 42 °C for 1 h.

In addition, the cDNA synthesized was applied in the PCR reaction containing 0.1-M cDNA, 2.5-µl 10× PCR buffer, 1-µl dNTP (10 mM), 0.8-µl MgCl2 (50 mM), 0.3 µl of each specific primer (forward and reverse 20 pM), 0.3-µl Taq DNA polymerase (Promega), as well as 19.7 µl of DEPC-treated water. The PCR reaction condition occurred at 94 °C for 1 min, followed by 35 cycles of 94 °C for 1 min, 55 °C for 1 min, and 72 °C for 1 min, with a final extension step of 72 °C for 1 min. The PCR products were analyzed by 1.5% agarose gel electrophoresis including 0.5% µl/ml ethidium bromide, and visualized by ultraviolet transilluminator (UVP). The forward primer: 5′-AAGATGTCAGCACCAGCTAG-3′ and reverse primer 5′-GTAGGCGTCGGTTATGTAGA-3′.

Flow cytometry

Tumor cell lines and MCF-12A non-tumorigenic epithelial breast cell line were implemented to study the toxicity of free-PVX, PVX–PVX, and free-HER. Accordingly, SKBR3 (2 × 105), SKOV3 (1 × 105), and MCF-12A (1 × 105) cells were seeded on a 12-well plate at 37 °C in a humidified atmosphere containing 5% CO2 incubator. SKBR3 and SKOV3 cells were grown in RPMI-1640, and MCF-12A was cultured in DMEM. The growth media were supplemented with 10% FBS (fetal bovine serum), penicillin, and streptomycin 10 μg of free-HER, free-PVX, and PVX–PVX were added on a 12-well plate for each cell, separately. At 24 h after the treatment, the cells were collected by trypsinization into their culture media, washed with PBS, and stained with Annexin V/propidium iodide (PI) Kit (BMS500 FI/100, eBioscience).The Annexin V/PI assay was conducted to determine cell apoptosis. In the next stage, the cells were analyzed after 10-min incubation by FACScan flow cytometer. Finally, Annexin V-binding and PI-binding were recognized to be apoptotic and necrotic, respectively. It is worth noting that all measurements were performed in triplicate.

Statistical analysis

To analyze the data, Mean ± SEM along with analysis of variance (ANOVA) with LSD post hoc test were used by SPSS 16.0 software. Before performing the parametric tests, normality distribution of the data sets was tested by Kolmogorov–Smimov and Shapiro–Wilk tests. The difference in values was considered as significant if the P value was less than 0.001. All experiments were performed in a triplicate and repeated at least three times.

Results

In this study, PVX particles were purified from systemically infected N. benthamiana leaves. The PVX was produced at the yields of 0.5–0.1-mg pure virus from 1-g infected plants. The concentration of PVX in plant extract was determined by UV–visible spectrometer (2.97 mg−1 ml−1 cm−1). SDS-PAGE and purity assessment of PVX were determined by a single protein band (27 kDa) and A260:280 ratio of 1.2, respectively. Recently, the conjugation of PVX to Herceptin (PVX-HER) was confirmed (Esfandiari et al. 2016). In the present study, the pathogenicity of PVX-HER in the plants was investigated by mechanical inoculation, ELISA, Western blot, and RT-PCR.

The mechanical inoculation of PVX-HER in N. benthamiana was inconsistent with the symptoms in the indicator plants. ELISA assay was set up to evaluate PVX detection in the extract samples from N. benthamiana inoculated with PVX-HER, free-PVX, and negative control. PVX antibody was employed to detect the virus infected samples. The 69% confidence intervals for the absorption mean (Mean ± SEM) in PVX-HER, free-PVX, and control were 0.207% ± 0.068, 3.66% ± 0.014, and 0.198% ± 0.008, respectively. In addition, the absorption of PVX-HER was not significantly different, compared to the control (P = 0.570). In addition, free-PVX could significantly increase the absorbance level compared to the PVX-HER and negative control (P ≤ 0.001) (Fig. 1).
Fig. 1

Analysis of PVX-HER in inoculated N. benthamiana by sandwich ELISA. Comparison of ELISA between free-PVX, PVX-HER, and control was performed using one-way analysis of variance (ANOVA) followed by LSD as post hoc test. The absorbance at a wavelength of 450 nm (Y-axis) is plotted along the X-axis (free-PVX, PVX-HER, and Control). Symbols on column indicate differences between free-PVX and PVX-HER with control. Asterisk symbols on brackets indicate difference between free-PVX and PVX-HER. **P ≤ 0.001. In the case of insignificant differences, the P values were mentioned on the column

Another approach used for confirming the non-pathogenicity of PVX-HER nanoparticle was obtained by SDS-PAGE and Western blotting. An equal amount of PVX-HER, free-PVX, and positive (purified PVX) and negative (healthy plant) control was separated by 4–12% acrylamide gels and transferred to a nitrocellulose membrane. After staining, a 27-kDa molecular weight coat protein of free-PVX was observed, but no 27-kDa band was shown for the extraction of N. benthamiana inoculated with PVX-HER as well as negative control (Fig. 2a). Furthermore, the protein was recognized by PVX-specific antibody. The Western blot analysis of nitrocellulose membrane exposed to PVX-specific antibody in free-PVX indicated a protein band with molecular weight of 27 kDa, while no band was observed in PVX-HER (Fig. 2b).
Fig. 2

Effect of PVX-HER on the pathogenicity in N. benthamiana by SDS-PAGE, Western blotting, and RT-PCR. a SDS-PAGE patterns of proteins from N. benthamiana plants harvested at 3-week post-infection inoculation: Line 1: The single protein band (27 kDa) of purified PVX, Line2: Protein Marker US7 (GeneON, 310001), Line 3: The extract of N. benthamiana leaves was not inoculated, Line 4: the extract of leaves with symptoms which inoculated with free-PVX; showing 27 kDa band of PVX CP in different bands of plant extract protein. Line 5: the extract of leaves without symptoms which inoculated with PVX-HER; the evidence of different bands of plant protein without protein band-related CP of PVX. b Analysis of inoculation on N. benthamiana by Western blotting with PVX-specific antibody. Line 1: no band is shown from the extract of inoculated leaves with PVX-HER. Line 2: 27 kDa single protein band of PVX from the extract of inoculated leaves with free-PVX interacted with PVX-specific antibody, Line 3: no band is shown from the extract of non-inoculated N. benthamiana leaves as a negative control. c RT-PCR detection of the PVX CP gene in inoculated N. benthamiana. Line 1: the inoculated leaves of free-PVX are indicated the presence of 714 bp band-size. The position of the amplification products corresponding to the CP of PVX is also represented, Line 2: The inoculated leaves with PVX-HER showed no evidence of specific band (714 bp) PVX CP amplification, Line, 3: non-inoculated leaves (negative control), Line4: Thermo scientific MassRuler Low Range DNA Ladder (MAN0013019)

Another important assay to study the samples was performed by RT-PCR. Polymerase chain reaction was used to evaluate the pathogenicity of these samples in the plants. RT-PCR amplification was obtained using specific primers. A fragment 714 bp was obtained to extract N. benthamiana inoculated with free-PVX, while no specific band was observed in N. benthamiana inoculated with PVX-HER (Fig. 2c).

The present study aimed to see whether PVX alone (free-PVX) and PVX conjugated to PVX (PVX–PVX) had any cytotoxicity in breast cancer (SKOV3 and SKBR3) and normal breast (MCF-12A). To this aim, 10 μg of free-HER, free-PVX, and PVX–PVX were treated in SKBR3, SKOV3, and MCF-12A cells in 24 h. Annexin V is a calcium-depending binding to phospholipids on the cell membrane. PI which cannot penetrate the intact membrane is used to differentiate between early apoptotic, late apoptotic, and necrotic cells. The ratio of apoptotic SKBR3 and SKOV3 cells decreased after treatment with free-PVX and PVX–PVX, compared to free-HER (Fig. 3). In addition, MCF-12A was not significantly influenced when treated with free-PVX, PVX–PVX, and free-HER, compared to the control sample.
Fig. 3

Flow cytometry analysis was performed for Annexin V-FITC (FL1) and Propidium iodide (FL3) on SKOV3 cells. a Control, b free-HER, c free-PVX, and d PVX–PVX, live cells are in the lower left quadrant (Q3), early apoptotic cells are in the lower right quadrant (Q4), and late apoptotic/necrotic cells are in the upper right quadrant (Q2). e Percentages of apoptotic cells (Y-axis) in SKBR3 (blue), SKOV3 (red), and MCF-12A (green) cells: control, free-PVX, PVX–PVX, and free-HER (X-axis)

For statistical analysis, the one-way analysis of variance (ANOVA) was performed on data related to the control, free-PVX, PVX–PVX, and free-HER. The change in apoptosis was considered as significant if the P value was less than 0.001 after using LSD post hoc tests. The average percentages of apoptotic SKBR3 cells in free-PVX, PVX–PVX, free-HER, and control were 1.282% ± 0.015, 1.193% ± 0.020, 24.393% ± 0.171, and 0.988% ± 0.018, respectively (Fig. 4a). Regarding SKOV3 treatment with free-PVX, PVX–PVX, free-HER, and control, the average percentages of apoptotic cells equaled to 0.994% ± 0.018, 1.194% ± 0.048, 22.10% ± 0.377, and 0.718% ± 0.013, respectively (Fig. 4b). Finally, the average percentages of MCF-12A cell apoptosis indicated 1.177% ± 0.042, 1.176% ± 0.045, 1.178% ± 0.033, and 1.175% ± 0.057 for control, free-PVX, PVX–PVX, free-HER, and control, respectively (Fig. 4c). In addition, SKOV3, SKBR3, and MCF-12A necrotic cells induced by free-PVX and PVX-HER were not induced.
Fig. 4

Analysis of the effect free-PVX, PVX–PVX, and free-HER on apoptosis in SKBR3 and SKOV3 cells. SKBR3 (a), SKOV3 (b), and MCF-12A (c) were cultured with control, free-PVX, PVX–PVX, and free-HER. The percentages of apoptotic were determined by Annexin-FITC and Propidium iodide (Y-axis). Values are mean ± SEM of four samples. Symbols on column indicate differences between free-PVX, PVX–PVX, and free-HER with control. Asterisk symbols on brackets indicate difference between free-PVX, PVX–PVX, and free-HER. **P ≤ 0.001. Otherwise, the P value was mentioned. In the case of insignificant differences, the P values were demonstrated on the column

Discussion

The increasing demands on nanotechnology have created some challenges regarding the potential risks of nanoparticles for human health and the environment. A few studies have addressed the toxicity of nanoparticles on bacteria, plants, and animals. Hence, it is necessary to study the toxicity of nanoparticles. Since viruses are self-assembled (Wen et al. 2012), stabilized (Steinmetz 2010), and biodegradable (Singh et al. 2007), they are expected to be good candidates as drug carriers. Researchers have addressed different uses for these carriers by non-pathogenic viruses. (Barwal et al. 2016; Grasso and Santi 2010; Lizotte et al. 2016; Love et al. 2014; Walker et al. 2011). As it was already mentioned, plant viruses are obviously preferred over other animal viruses as they are non-infectious in humans (Steinmetz 2010). Therefore, plant virus nanoparticles are regarded as attractive platforms in nanobiotechnology.

The plant virus capsids involve two kinds of structures including helical and icosahedral symmetry. In helical capsids, the protein subunits are arranged in a helix around the viral RNA, while the subunits are assembled in the form of quasi-spherical structure covering the genome in icosahedral symmetry (Caspar and Klug 1962).

In the present study, a filamentous virus was used due to some advantages to isometric viruses, although most plant viruses employed for drug carriers are isometric (Esfandiari et al. 2016).

In general, interior, exterior, and interface methods are used for loading drug. The exterior surface plays an important role in conjugation with drugs. The conjugation is accomplished by amine, carboxylic acid, and thiol groups (de la Escosura et al. 2009). Accordingly, carboxyl group of heavy chains of Herceptin was conjugated to amine group of PVX nanoparticles by EDC/sulfo-NHS cross linker. In fact, Herceptin is a drug used for treating some breast cancer patients. However, Herceptin is extremely expensive drug with a wide range of unpleasant side effects. The conjugation of Herceptin to nanoparticles can enhanced the efficacy and reduce dosage and side effects among breast cancer patients (Esfandiari et al. 2016).

Based on the previous study, PVX nanoparticles, as the result of conjugation of PVX to Herceptin (PVX-HER), could significantly increase the death rate of cancer cells (Esfandiari 2013; Esfandiari et al. 2016). VNPs have been studied from a different environmental perspective, which is regarded as the big concern in using viruses as nanoparticles. A question raised here is whether PVX-HER infects plants or in other words, the conjugation of Herceptin to the exterior of plant virus can create harmful environmental effects. In addition, as another question, the present study aimed to see whether free-HER and PVX–PVX can have toxicity on animal cell lines.

PVX is considered as one of the important viral pathogens in many plants, and it is extremely easy to transmit mechanically in the field by contacting with a healthy and infected leaves. Thus, this study could contribute to investigate the pathogenesis of PVX-HER nanoparticle in plants by mechanical inoculation of symptoms on N. benthamiana, which is the main host of the virus. After 3 weeks, free-PVX caused mosaic symptoms on N. benthamiana, while PVX-HER had no symptoms in this plant simultaneously. The molecular and serological testing methods were employed to detect the virus to ensure the non-pathogenicity of PVX-HER. ELISA is the first screening test which is widely used to investigate PVX-HER in inoculated N. benthamiana. In this method, PVX-specific antibodies were used as a capture, and accordingly, goat polyclonal secondary antibody was added. Thus, this test could detect the samples including free-PVX, while negative results were obtained for the extracts of the inoculated N. benthamiana leaves with PVX-HER. In addition, a significance difference was obtained between free-PVX and PVX-HER (P ≤ 0.001). Then, SDS-PAGE was employed to extract the inoculated N. benthamiana leaves with PVX-HER. The weight of coat protein of purified PVX and free-PVX from N. benthamiana equaled to 27 kDa, although no band was observed in the inoculated N. benthamiana PVX-HER, compared to free-PVX. The Western blot was used to confirm the findings of SDS-PAGE by PVX-specific antibody. Western blot was able to identify a specific 27-kDa coat protein band of purified PVX. Furthermore, no band was shown in the inoculated leaves of N. benthamiana with PVX-HER.

Finally, reverse transcription PCR (RT-PCR) was utilized to obtain more accurate evaluation results. For this purpose, the nucleic acid of the inoculated N. benthamiana with PVX-HER, the inoculated N. benthamiana with free-PVX, and healthy N. benthamiana were extracted. Then, PVX CP-specific primers were employed to amplify the PVX CP gene. The inoculated plant with free-PVX from genomic nucleic acid including the PVX CP gene with the primers was amplified in a 712-bp product. Based on the results, the inoculated N. benthamiana with PVX-HER RNA yielded no PCR products, which confirmed that the conjugation of the PVX with Herceptin could cause the virus loses its infectivity. In other words, pathogenesis does not take place in plants which are considered as a host of this virus after conjugating PVX to Herceptin.

Based on this hypothesis, virus particles lose their pathogenesis after the drug conjugates to the exterior surface of virus capsid. In other words, conjugating Herceptin to the PVX surface using EDC/Sulfo-NHS linker can inhibit disassembly, which is regarded as important for replicating and infecting virus. Based on the results of ELISA, Western blot, and RT-PCR tests, RNA genome replication of the virus could lose its replication after conjugating and creating PVX-HER nanoparticle. Regarding the results of present study, the use of VNPs for conjugating drugs or chemicals to the exterior surface of the VNPs can cause the viral nucleic acid to lose its activity and the pathogenicity in plants. To our knowledge, since the same survey has not been conducted so far and the perspective of environmental pollution of VNPs has not been investigated yet, so there is a great potential to follow research in this subject.

Regarding the second question, the previous studies demonstrated that PVX-HER was more effective than free-HER in cell apoptosis and necrosis in the human HER2+ breast cancer cell lines (Esfandiari et al. 2016). The present study aimed to investigate the effect of PVX-HER nanoparticle on the plants and influence of free-PVX on human cells. In addition, the self-conjugate PVX (PVX–PVX) was used. In fact, the goal was to determine whether the PVX-HER initiated toxicity in cells is under the influence of PVX nanoparticles or possibly due to chemical compounds used in the conjugation process. For this purpose, the effect of nanoparticle HER-PVX, PVX–PVX, and free-PVX on HER2-positive cell lines (SKOV3-SKBR3) and non-tumorigenic epithelial breast cell line was examined by flow cytometry. It was observed that, in average, no significant difference was observed in apoptosis between PVX–PVX, free-PVX, and control in SKOV3 and SKBR3 cell lines after 24 h (P ≥ 0.001). Furthermore, no significant difference was reported in normal cells, treated with PVX–PVX, free-PVX, free-HER, and control after 24 h (P ≥ 0.001). Therefore, the toxicity of PVX-HER nanoparticle on HER2-positive cell lines is not related to a direct effect of this plant virus on human cells, while it is more concerned with the delivering the controlled drug and releasing Herceptin to target cells after binding to the virus and generating PVX-HER nanoparticle.

In conclusion, the present study indicated that PVX-HER nanoparticles are not non-pathogenic to their host plants and free-PVX is not toxic to human cell lines.

Conclusion

In recent years, viral nanoparticles have attracted a lot of attention. In this area, a large body of research has been conducted. However, the present study has opened a new dimension into this field. The results demonstrate that viral nanoparticles are not toxic and they are safe for organism and environment. Finally, VNP is expected to be revolutionized in many different fields such as agricultural, medical, and industrial sectors during the next few years.

Abbreviations

VNPs: 

viral nanoparticles

HER2: 

human epidermal growth factor receptor2

PVX: 

Potato Virus X

PVX-HER: 

Potato Virus X conjugated to Herceptin

ELISA: 

enzyme-linked immunosorbent assay

RT-PCR: 

reverse transcription polymerase chain reaction

Free-PVX: 

PVX that is not conjugated with Herceptin

Free- Herceptin: 

Herceptin that is not conjugated with PVX

SKBR3: 

homosapiens breast

SKOV3: 

homosapiens ovary

PVX–PVX: 

PVX conjugated with PVX

SDS-PAGE: 

sodium dodecyl sulfate polyacrylamide gel electrophoresis

PBST: 

phosphate buffered saline with tween20

HRP: 

horseradish peroxidase

PVP: 

polyvinylpyrrolidone

mAb: 

monoclonal antibody

kDa: 

kilodalton

bp: 

base pair

Declarations

Authors’ contributions

NE designed and performed experiments, prepared figures, and wrote the main text. MK and MKH contributed with valuable discussions. All authors reviewed the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The research of Neda Esfandiari was in part supported by a grant from Shahid Beheshti University, G.C. (No. 600/1312). The authors are grateful to Dr. Alireza Taheriyoun for his fruitful statistical discussion. Moreover, they are very grateful for the useful comments provided by the three reviewers.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The data sets supporting the conclusions of this article are included within the article.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

The research of Neda Esfandiari was in part supported by a grant from Shahid Beheshti University, G.C. (No. 600/1312).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in the published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Protein Research Center, Shahid Beheshti University, G.C., Tehran, Iran
(2)
Department of Molecular Medicine, Pasteur Institute, Tehran, Iran
(3)
Department of Medicine, Karolinska Institute, Solna, Sweden
(4)
Department of Plant Protection, Faculty of Sciences and Plant Protection, University of Tehran, Tehran, Iran

References

  1. Aguilar E, del Toro FJ, Chung BN, Canto T, Tenllado F, Island J. Infection of Nicotiana benthamiana plants with Potato Virus X (PVX). Bio-protocol. 2016;6:e2063. https://doi.org/10.21769/BioProtoc.2063.View ArticleGoogle Scholar
  2. Allan Granoff RGW. Encyclopedia of Virology, vol. 1997. Cambridge: Academic Press; 1999.Google Scholar
  3. Aniagyei SE, DuFort C, Kao CC, Dragnea B. Self-assembly approaches to nanomaterial encapsulation in viral protein cages. J Mater Chem. 2008;18:3763–74. https://doi.org/10.1039/b805874c.View ArticleGoogle Scholar
  4. Armuss A. Breast cancer update. Versicherungsmedizin. 2014;66:68–71.Google Scholar
  5. Bance VB. Replication of Potato Virus X RNA is altered in coinfections with potato virus Y. Virology. 1991;182:486–94.View ArticleGoogle Scholar
  6. Barwal I, Kumar R, Kateriya S, Dinda AK, Yadav SC. Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex. Sci Rep. 2016;6:37096.View ArticleGoogle Scholar
  7. Bayne EH, Rakitina DV, Morozov SY, Baulcombe DC. Cell-to-cell movement of Potato Potexvirus X is dependent on suppression of RNA silencing. Plant J. 2005;44:471–82.View ArticleGoogle Scholar
  8. Biabanikhankahdani R, Alitheen NB, Ho KL, Tan WS. pH-responsive virus-like nanoparticles with enhanced tumour-targeting ligands for cancer drug delivery. Sci Rep. 2016;6:37891. https://doi.org/10.1038/srep37891.View ArticleGoogle Scholar
  9. Bruckman MA, Randolph LN, VanMeter A, Hern S, Shoffstall AJ, Taurog RE, Steinmetz NF. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and-spheres in mice. Virology. 2014;449:163–73.View ArticleGoogle Scholar
  10. Campos SK, Barry MA. Current advances and future challenges in adenoviral vector biology and targeting. Curr Gene Ther. 2007;7:189–204. https://doi.org/10.2174/156652307780859062.View ArticleGoogle Scholar
  11. Caspar DL, Klug A. Physical principles in the construction of regular viruses. In Cold Spring Harbor symposia on quantitative biology, vol. 27. New york: Cold Spring Harbor Laboratory Press; 1962. p. 1–24.Google Scholar
  12. Culver JN, Brown AD, Zang F, Gnerlich M, Gerasopoulos K, Ghodssi R. Plant virus directed fabrication of nanoscale materials and devices. Virology. 2015;479:200–12.View ArticleGoogle Scholar
  13. de la Escosura A, Nolte RJ, Cornelissen JJ. Viruses and protein cages as nanocontainers and nanoreactors. J Mater Chem. 2009;19:2274–8.View ArticleGoogle Scholar
  14. Esfandiari N. Bioconjugation of Herceptin antibody to Potato Virus X nanoscafold as a new application for Breast Cancer. Ph.D. thesis, University of Tehran. 2013.Google Scholar
  15. Esfandiari N, Arzanani MK, Soleimani M, Kohi-Habibi M, Svendsen WE. A new application of plant virus nanoparticles as drug delivery in breast cancer. Tumor Biology. 2016;37:1229–36. https://doi.org/10.1007/s13277-015-3867-3.View ArticleGoogle Scholar
  16. Esfandiari N, Habibi MK, Mosahebi G. New indicator plants for Potato Virus X. Commun Agric Appl Biol Sci. 2006;71:1275–80.Google Scholar
  17. Esfandiari N, Kohi-Habibi M, Hohn T, Pooggin MM. Complete genome sequence of an Iranian isolate of Potato Virus X from the legume plant Pisum sativum. Virus Genes. 2009;39:141–5. https://doi.org/10.1007/s11262-009-0371-0.View ArticleGoogle Scholar
  18. Goodin MM, Zaitlin D, Naidu RA, Lommel SA. Nicotiana benthamiana: its history and future as a model for plant–pathogen interactions. Mol Plant Microbe Interact. 2008;21:1015–26.View ArticleGoogle Scholar
  19. Grasso S, Santi L. Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches. Int J Physiol Pathophysiol Pharmacol. 2010;2:161–78.Google Scholar
  20. Hefferon K. Plant virus nanoparticles: new applications and new benefits. Future Virol. 2016;11:591–9. https://doi.org/10.2217/fvl-2016-0059.View ArticleGoogle Scholar
  21. Hudis CA. Trastuzumab—mechanism of action and use in clinical practice. N Engl J Med. 2007;357:39–51.View ArticleGoogle Scholar
  22. King A, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Virus Taxonomy—ninth report of the international committee on taxonomy of viruses. London: Elsevier/Academic Press; 2011.Google Scholar
  23. Le DH, Lee KL, Shukla S, Commandeur U, Steinmetz NF. Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy. Nanoscale. 2017;9:2348–57.View ArticleGoogle Scholar
  24. Lebel ME, Chartrand K, Tarrab E, Savard P, Leclerc D, Lamarre A. Potentiating cancer immunotherapy using papaya mosaic virus-derived nanoparticles. Nano Lett. 2016;16:1826–32. https://doi.org/10.1021/acs.nanolett.5b04877.View ArticleGoogle Scholar
  25. Lee KL, Twyman RM, Fiering S, Steinmetz NF. Virus-based nanoparticles as platform technologies for modern vaccines. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8:554–78. https://doi.org/10.1002/wnan.1383.View ArticleGoogle Scholar
  26. Lico C, Benvenuto E, Baschieri S. The two-faced Potato Virus X: from plant pathogen to smart nanoparticle. Front Plant Sci. 2015;6:1009.View ArticleGoogle Scholar
  27. Lizotte PH, Wen AM, Sheen MR, Fields J, Rojanasopondist P, Steinmetz NF, Fiering S. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. Nat Nanotechnol. 2016;11:295–303. https://doi.org/10.1038/nnano.2015.292.View ArticleGoogle Scholar
  28. Love AJ, Makarov V, Yaminsky I, Kalinina NO, Taliansky ME. The use of tobacco mosaic virus and cowpea mosaic virus for the production of novel metal nanomaterials. Virology. 2014;449:133–9.View ArticleGoogle Scholar
  29. Manchester M, Singh P. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Adv Drug Deliv Rev. 2006;58:1505–22. https://doi.org/10.1016/j.addr.2006.09.014.View ArticleGoogle Scholar
  30. Mentaberry A, Orman B. Potexviruses. In: Sing RP, Singh US, Kohmoto K, editors. Pathogenesis and host specificity in plant diseases. Histopathological, biochemical, genetic and molecular bases. Viruses and viroids, vol. 3; 1995. p . 19–33. Google Scholar
  31. Mody N, Tekade RK, Mehra NK, Chopdey P, Jain NK. Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential. AAPS PharmSciTech. 2014;15:388–99. https://doi.org/10.1208/s12249-014-0073-3.View ArticleGoogle Scholar
  32. Niu Z, et al. Assembly of tobacco mosaic virus into fibrous and macroscopic bundled arrays mediated by surface aniline polymerization. Langmuir. 2007;23:6719–24. https://doi.org/10.1021/la070096b.View ArticleGoogle Scholar
  33. Peruzzi PP, Chiocca EA. Cancer immunotherapy: a vaccine from plant virus proteins. Nat Nanotechnol. 2016;11:214–5. https://doi.org/10.1038/nnano.2015.306.View ArticleGoogle Scholar
  34. Rong J, Lee LA, Li K, Harp B, Mello CM, Niu Z, Wang Q. Oriented cell growth on self-assembled bacteriophage M13 thin films. Chem Commun. 2008;41:5185–87. https://doi.org/10.1039/b811039e.View ArticleGoogle Scholar
  35. Salazar JA. Basic techniques in plant virology. Lima: CIP pathology Dept. Technical training Unit No. 1; 1993.Google Scholar
  36. Senanayake D, Mandal B. Expression of symptoms, viral coat protein and silencing suppressor gene during mixed infection of a N–Wi strain of Potato Virus Y and an asymptomatic strain of Potato Virus X. VirusDisease. 2014;25:314–21.View ArticleGoogle Scholar
  37. Shukla S, Ablack AL, Wen AM, Lee KL, Lewis JD, Steinmetz NF. Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato Virus X. Mol Pharm. 2013;10:33–42. https://doi.org/10.1021/mp300240m.View ArticleGoogle Scholar
  38. Singh P, et al. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J Control Release. 2007;120:41–50. https://doi.org/10.1016/j.jconrel.2007.04.003.View ArticleGoogle Scholar
  39. Steinmetz NF. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomed Nanotechnol Biol Med. 2010;6:634–41. https://doi.org/10.1016/j.nano.2010.04.005.View ArticleGoogle Scholar
  40. Steinmetz NF. Viral nanoparticles in drug delivery and imaging. Mol Pharm. 2013;10:1–2. https://doi.org/10.1021/mp300658j.View ArticleGoogle Scholar
  41. Van Kan-Davelaar HE, Van Hest JCM, Cornelissen JJLM, Koay MST. Using viruses as nanomedicines. Br J Pharmacol. 2014;171:4001–9. https://doi.org/10.1111/bph.12662.View ArticleGoogle Scholar
  42. Walker A, Skamel C, Nassal M. SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure. Sci Rep. 2011;1:5. https://doi.org/10.1038/srep00005.View ArticleGoogle Scholar
  43. Wen AM, et al. Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromol. 2012;13:3990–4001. https://doi.org/10.1021/bm301278f.View ArticleGoogle Scholar
  44. Yoo JW, Irvine DJ, Discher DE, Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov. 2011;10:521–35. https://doi.org/10.1038/nrd3499.View ArticleGoogle Scholar
  45. Young M, Debbie W, Uchida M, Douglas T. Plant viruses as biotemplates for materials and their use in nanotechnology. Annu Rev Phytopathol. 2008;46:361–84. https://doi.org/10.1146/annurev.phyto.032508.131939.View ArticleGoogle Scholar
  46. Zhao Y, Owens RA, Hammond RW. Use of a vector based on potato virus X in a whole plant assay to demonstrate nuclear targeting of potato spindle tuber viroid. J Gen Virol. 2001;82:1491–7.View ArticleGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement